143 related articles for article (PubMed ID: 2555048)
21. Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines.
Robson H; Meyer S; Shalet SM; Anderson E; Roberts S; Eden OB
Med Pediatr Oncol; 2002 Dec; 39(6):573-80. PubMed ID: 12376980
[TBL] [Abstract][Full Text] [Related]
22. The importance of schedule on diethyldithiocarbamate modulation of drug-induced myelosuppression.
East CJ; Borch RF
Cancer Chemother Pharmacol; 1992; 31(2):123-6. PubMed ID: 1333368
[TBL] [Abstract][Full Text] [Related]
23. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.
Kido Y; Khokhar AR; al-Baker S; Siddik ZH
Cancer Res; 1993 Oct; 53(19):4567-72. PubMed ID: 8402629
[TBL] [Abstract][Full Text] [Related]
24. The effect of diethyldithiocarbamate on the haematological toxicity and antitumour activity of carboplatin.
Dible SE; Siddik ZH; Boxall FE; Harrap KR
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):813-8. PubMed ID: 2820745
[TBL] [Abstract][Full Text] [Related]
25. A murine model to evaluate the ability of in vitro clonogenic assays to predict the response to tumors in vivo.
Mirabelli CK; Sung CM; McCabe FL; Faucette LF; Crooke ST; Johnson RK
Cancer Res; 1988 Oct; 48(19):5447-54. PubMed ID: 3046738
[TBL] [Abstract][Full Text] [Related]
26. Effects of high-dose methotrexate and leucovorin on murine hemopoietic stem cells.
Pannacciulli I; Massa G; Bogliolo G; Ghio R; Sobrero A
Cancer Res; 1982 Feb; 42(2):530-4. PubMed ID: 6976827
[TBL] [Abstract][Full Text] [Related]
27. Enhanced therapeutic efficacy of cisplatin by combination with diethyldithiocarbamate and hyperthermia in a mouse model.
Murthy MS; Rao LN; Khandekar JD; Scanlon EF
Cancer Res; 1987 Feb; 47(3):774-9. PubMed ID: 3026616
[TBL] [Abstract][Full Text] [Related]
28. AM5, a protein-associated polysaccharide, stimulates hematopoiesis and modulates the expression of endogenous hematopoietic growth factors in murine long-term bone marrow cultures.
Güenechea G; Bueren JA; Maganto G; Tuduri P; Guerrero A; Pivel JP; Real A
Stem Cells; 1995 Mar; 13(2):175-85. PubMed ID: 7540471
[TBL] [Abstract][Full Text] [Related]
29. Preclinical evaluation of WR-151327: an orally active chemotherapy protector.
Green D; Bensely D; Schein P
Cancer Res; 1994 Feb; 54(3):738-41. PubMed ID: 8306335
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic and pharmacological studies of tetrachloro(d,l-trans)1,2-diaminocyclohexane platinum (IV) (tetraplatin), a new platinum analogue.
Rahman A; Roh JK; Wolpert-DeFilippes MK; Goldin A; Venditti JM; Woolley PV
Cancer Res; 1988 Apr; 48(7):1745-52. PubMed ID: 3162402
[TBL] [Abstract][Full Text] [Related]
31. In vitro antitumor activity of a new platinum complex, DWA2114R against human tumor cell lines.
Akamatsu K; Saito H; Tsunenari T; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
Anticancer Res; 1993; 13(6A):2261-5. PubMed ID: 8297143
[TBL] [Abstract][Full Text] [Related]
32. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis.
Scheding S; Media JE; Nakeff A
Exp Hematol; 1994 Jan; 22(1):60-5. PubMed ID: 8282060
[TBL] [Abstract][Full Text] [Related]
33. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
Siddik ZH; al-Baker S; Thai G; Khokhar AR
Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
[TBL] [Abstract][Full Text] [Related]
34. Monitoring of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in cells from platinum-treated cancer patients.
Terheggen PM; Dijkman R; Begg AC; Dubbelman R; Floot BG; Hart AA; den Engelse L
Cancer Res; 1988 Oct; 48(19):5597-603. PubMed ID: 3046743
[TBL] [Abstract][Full Text] [Related]
35. Goralatide (AcSDKP) selectively protects murine hematopoietic progenitors and stem cells against hyperthermic damage.
Wierenga PK; Konings AW
Exp Hematol; 1996 Feb; 24(2):246-52. PubMed ID: 8641348
[TBL] [Abstract][Full Text] [Related]
36. Combined interleukin-1 beta/interleukin-6 treatment in mice: synergistic myelostimulatory activity and myelorestorative effect after cyclophosphamide-induced myelosuppression.
Tritarelli E; Greco G; Testa U; Belardelli F; Peschle C; Proietti E
Cancer Res; 1994 Dec; 54(24):6469-76. PubMed ID: 7987845
[TBL] [Abstract][Full Text] [Related]
37. Retrovirus-mediated expression of a DNA repair protein in bone marrow protects hematopoietic cells from nitrosourea-induced toxicity in vitro and in vivo.
Moritz T; Mackay W; Glassner BJ; Williams DA; Samson L
Cancer Res; 1995 Jun; 55(12):2608-14. PubMed ID: 7780976
[TBL] [Abstract][Full Text] [Related]
38. Antitumor effect of carboplatin combined with radiation on tumors in mice.
Aratani Y; Yoshiga K; Mizuuchi H; Jo A; Tanimoto K; Sakurai K
Anticancer Res; 1997; 17(4A):2535-8. PubMed ID: 9252676
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of benzoporphyrin derivative, a photosensitizer, in selective destruction of leukemia cells using a murine tumor model.
Jamieson C; Richter A; Levy JG
Exp Hematol; 1993 May; 21(5):629-34. PubMed ID: 8513863
[TBL] [Abstract][Full Text] [Related]
40. Cain's quinolinium (NSC 176319): protection of murine L1210 leukemia cells and bone marrow progenitor cells against mechlorethamine cytotoxicity and its application to combination chemotherapy.
Naujokaitis SA
Res Commun Chem Pathol Pharmacol; 1981 Oct; 34(1):97-104. PubMed ID: 7313308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]